Rajoshi Chaudhuri

发表

Long term stability of a HIV-1 neutralizing monoclonal antibody using isothermal calorimetry.

E. Freire, A. Schön, L. Kueltzo, 2018, Analytical biochemistry.

Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody

J. Mascola, E. Reinherz, G. Chuang, 2018, Cell reports.

Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant.

J. Mascola, M. Sastry, I. Georgiev, 2016, Bioconjugate chemistry.

Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen

J. Mascola, G. Chuang, Reda Rawi, 2020, Scientific Reports.

Effect of acrylodan conjugation and forced oxidation on the structural integrity, conformational stability, and binding activity of a glucose binding protein SM4 used in a prototype continuous glucose monitor

A. Metters, S. Joshi, D. Volkin, 2017, Protein science : a publication of the Protein Society.

Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies

J. Mascola, G. Chuang, Baoshan Zhang, 2020, mAbs.

Preformulation Characterization, Stabilization, and Formulation Design for the Acrylodan-Labeled Glucose-Binding Protein SM4-AC.

A. Metters, S. Joshi, D. Volkin, 2017, Journal of pharmaceutical sciences.

High-Throughput Biophysical Analysis of Protein Therapeutics to Examine Interrelationships Between Aggregate Formation and Conformational Stability

D. Volkin, Rajoshi Chaudhuri, C. Middaugh, 2013, The AAPS Journal.

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.

Zonghui Hu, A. McDermott, J. Gall, 2023, The Lancet. Infectious diseases.

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Carmen M. Graves, J. Mascola, R. Koup, 2023, Science Translational Medicine.